LncRNA MEG3 can be a promising biomarker for ovarian cancer diagnosis and treatment by modifying the epithelial-mesenchymal transsition of ovarian cancer cells through sponging miR-219a-5p and modulating EGFR [20]. This evidence concerns the gene MEG3 and ovarian cancer.